706 related articles for article (PubMed ID: 10469378)
1. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.
Rix M; Andreassen H; Eskildsen P; Langdahl B; Olgaard K
Kidney Int; 1999 Sep; 56(3):1084-93. PubMed ID: 10469378
[TBL] [Abstract][Full Text] [Related]
2. Studies on bone markers and bone mineral density in patients with chronic renal failure.
Ha SK; Park CH; Seo JK; Park SH; Kang SW; Choi KH; Lee HY; Han DS
Yonsei Med J; 1996 Oct; 37(5):350-6. PubMed ID: 8997167
[TBL] [Abstract][Full Text] [Related]
3. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density and biochemical markers of bone metabolism in predialysis patients with chronic kidney disease.
Fidan N; Inci A; Coban M; Ulman C; Kursat S
J Investig Med; 2016 Apr; 64(4):861-6. PubMed ID: 26969749
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
6. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
7. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
Szulc P; Munoz F; Marchand F; Chapuy MC; Delmas PD
Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693
[TBL] [Abstract][Full Text] [Related]
8. A new approach for evaluating bone turnover in chronic kidney disease.
Tolouian R; Hernandez GT; Chiang WY; Gupta A
Eur J Intern Med; 2010 Jun; 21(3):230-2. PubMed ID: 20493428
[TBL] [Abstract][Full Text] [Related]
9. [Markers of calcium--phosphate metabolism and bones alterations in long term kidney transplant patients].
Spiechowicz U; Kokot F; Wiecek A
Przegl Lek; 2003; 60(11):690-4. PubMed ID: 15058034
[TBL] [Abstract][Full Text] [Related]
10. Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure.
Rix M; Eskildsen P; Olgaard K
Nephrol Dial Transplant; 2004 Apr; 19(4):870-6. PubMed ID: 15031343
[TBL] [Abstract][Full Text] [Related]
11. Skeletal status in children and adolescents with chronic renal failure before onset of dialysis or on dialysis.
Pluskiewicz W; Adamczyk P; Drozdzowska B; Szprynger K; Szczepańska M; Halaba Z; Karasek D
Osteoporos Int; 2003 Jun; 14(4):283-8. PubMed ID: 12730774
[TBL] [Abstract][Full Text] [Related]
12. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.
Tomida K; Hamano T; Mikami S; Fujii N; Okada N; Matsui I; Nagasawa Y; Moriyama T; Ito T; Imai E; Isaka Y; Rakugi H
Bone; 2009 Apr; 44(4):678-83. PubMed ID: 19111635
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of osteocalcin and CrossLaps as markers of bone turnover in children with chronic renal failure].
Polak-Jonkisz D; Zwolińska D; Bednorz R; Owczarek H; Nahaczewska W
Pol Merkur Lekarski; 2002 Apr; 12(70):257-60. PubMed ID: 12089882
[TBL] [Abstract][Full Text] [Related]
14. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
O'Flaherty D; Sankaralingam A; Scully P; Manghat P; Goldsmith D; Hampson G
Clin Biochem; 2013 Oct; 46(15):1405-9. PubMed ID: 23830844
[TBL] [Abstract][Full Text] [Related]
15. [Skeletal scintigraph and some bone turnover markers in the diagnosis of renal osteodystrophy in hemodialysis patients].
Bednarek-Skublewska A; Chrapko B; Ksiazek A
Pol Arch Med Wewn; 2003 Sep; 110(3):943-50. PubMed ID: 14699686
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure.
Tsuchida T; Ishimura E; Miki T; Matsumoto N; Naka H; Jono S; Inaba M; Nishizawa Y
Osteoporos Int; 2005 Feb; 16(2):172-9. PubMed ID: 15164161
[TBL] [Abstract][Full Text] [Related]
17. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
[TBL] [Abstract][Full Text] [Related]
18. Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study.
Jørgensen HS; Winther S; Bøttcher M; Hauge EM; Rejnmark L; Svensson M; Ivarsen P
BMC Nephrol; 2017 Sep; 18(1):284. PubMed ID: 28874132
[TBL] [Abstract][Full Text] [Related]
19. Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.
Avila-Díaz M; Matos M; García-López E; Prado MD; Castro-Vázquez F; Ventura MD; González E; Amato D; Paniagua R
Perit Dial Int; 2006; 26(1):78-84. PubMed ID: 16538879
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure].
Ziółkowska H; Roszkowska-Blaim M
Przegl Lek; 2006; 63 Suppl 3():149-52. PubMed ID: 16898516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]